Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 23866958)

1.

Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis.

Taylor MJ, Hoerauf A, Townson S, Slatko BE, Ward SA.

Parasitology. 2014 Jan;141(1):119-27. doi: 10.1017/S0031182013001108. Epub 2013 Jul 18. Review.

2.

Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.

Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, Faragher B, Specht S, Mand S, Hoerauf A, Enyong P, Wanji S, Taylor MJ.

PLoS Negl Trop Dis. 2010 Apr 13;4(4):e660. doi: 10.1371/journal.pntd.0000660.

3.

Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.

Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Büttner DW.

Med Microbiol Immunol. 2003 Nov;192(4):211-6. Epub 2003 Mar 5.

PMID:
12684759
4.

Filariasis in Africa--treatment challenges and prospects.

Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S.

Clin Microbiol Infect. 2011 Jul;17(7):977-85. doi: 10.1111/j.1469-0691.2011.03586.x. Review.

5.

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study.

Hoerauf A, Specht S, Büttner M, Pfarr K, Mand S, Fimmers R, Marfo-Debrekyei Y, Konadu P, Debrah AY, Bandi C, Brattig N, Albers A, Larbi J, Batsa L, Taylor MJ, Adjei O, Büttner DW.

Med Microbiol Immunol. 2008 Sep;197(3):295-311. Epub 2007 Nov 13. Erratum in: Med Microbiol Immunol. 2008 Sep;197(3):335. Taylor, Mark J [added].

6.

Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus.

Hoerauf A, Specht S, Marfo-Debrekyei Y, Büttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C, Fimmers R, Adjei O, Büttner DW.

Parasitol Res. 2009 Jan;104(2):437-47. doi: 10.1007/s00436-008-1217-8. Epub 2008 Oct 11.

PMID:
18850111
7.

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.

Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW.

Lancet. 2001 May 5;357(9266):1415-6.

PMID:
11356444
8.

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

Mackenzie CD, Geary TG.

Expert Rev Anti Infect Ther. 2011 May;9(5):497-501. doi: 10.1586/eri.11.30. No abstract available.

PMID:
21609260
9.

Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis.

Hoerauf A.

Curr Opin Infect Dis. 2008 Dec;21(6):673-81. doi: 10.1097/QCO.0b013e328315cde7. Review.

PMID:
18978537
10.

Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.

Tamarozzi F, Tendongfor N, Enyong PA, Esum M, Faragher B, Wanji S, Taylor MJ.

Parasit Vectors. 2012 Mar 20;5:53. doi: 10.1186/1756-3305-5-53.

11.

Lymphatic filariasis and onchocerciasis.

Taylor MJ, Hoerauf A, Bockarie M.

Lancet. 2010 Oct 2;376(9747):1175-85. doi: 10.1016/S0140-6736(10)60586-7. Epub 2010 Aug 23. Review.

PMID:
20739055
12.

Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus.

Specht S, Mand S, Marfo-Debrekyei Y, Debrah AY, Konadu P, Adjei O, Büttner DW, Hoerauf A.

Parasitol Res. 2008 Nov;103(6):1303-9. doi: 10.1007/s00436-008-1133-y. Epub 2008 Aug 5.

PMID:
18679718
13.

Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.

Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Büttner DW.

Microbes Infect. 2003 Apr;5(4):261-73.

PMID:
12706439
14.

Antibiotics for the treatment of onchocerciasis and other filarial infections.

Hoerauf A, Adjei O, Büttner DW.

Curr Opin Investig Drugs. 2002 Apr;3(4):533-7. Review.

PMID:
12090719
15.

Progress and challenges in the discovery of macrofilaricidal drugs.

Geary TG, Mackenzie CD.

Expert Rev Anti Infect Ther. 2011 Aug;9(8):681-95. doi: 10.1586/eri.11.76. Review.

PMID:
21819332
16.

Elimination of lymphatic filariasis: do we have the drugs to complete the job?

Bockarie MJ, Deb RM.

Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5. Review.

PMID:
20847694
17.

Wolbachia bacteria of filarial nematodes: a target for control?

Taylor MJ, Bandi C, Hoerauf AM, Lazdins J.

Parasitol Today. 2000 May;16(5):179-80. No abstract available.

PMID:
10782070
18.

The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target.

Wu B, Novelli J, Foster J, Vaisvila R, Conway L, Ingram J, Ganatra M, Rao AU, Hamza I, Slatko B.

PLoS Negl Trop Dis. 2009 Jul 14;3(7):e475. doi: 10.1371/journal.pntd.0000475.

19.

Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus.

Hoerauf A, Marfo-Debrekyei Y, Büttner M, Debrah AY, Konadu P, Mand S, Adjei O, Büttner DW.

Parasitol Res. 2008 Jul;103(2):279-86. doi: 10.1007/s00436-008-0964-x. Epub 2008 Apr 18.

PMID:
18421478
20.

New insights into the biology of filarial infections.

Specht S, Wanji S.

J Helminthol. 2009 Jun;83(2):199-202. doi: 10.1017/S0022149X09344922. Epub 2009 Apr 20. Review.

PMID:
19379544
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk